文献速递类风湿关节炎

瓜氨酸化并非类风湿关节炎中抗PAD2和PAD4自身抗体识别的关键决定因素

Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis.
PubMed 文献 · Arthritis Rheumatol · 2020-07-14

研究纳入184例类风湿关节炎(RA)患者,用质谱和文献复习确定PAD2和PAD4的自瓜氨酸化位点,ELISA检测抗天然及自瓜氨酸化PAD抗体。结果显示自瓜氨酸化不影响大多数RA患者抗PAD抗体与PAD2或PAD4的结合,提示抗PAD抗体与抗瓜氨酸化蛋白抗体(ACPA)对瓜氨酸化的依赖性不同。

要点

  • 自瓜氨酸化不改变大多数RA患者抗PAD2和PAD4抗体的结合反应性。
  • 抗PAD抗体与ACPA不同,其识别PAD不依赖瓜氨酸化状态。
  • 仅少数抗PAD阳性血清优先识别天然或瓜氨酸化PAD。

核心结论

  • 自瓜氨酸化不影响大多数RA患者抗PAD2和PAD4抗体与PAD的结合,抗PAD抗体识别PAD不依赖瓜氨酸化,与ACPA不同。

研究设计与样本

  • 研究通过质谱和文献复习确定PAD2和PAD4的自瓜氨酸化位点,用ELISA检测184例RA患者血清中抗天然及自瓜氨酸化PAD2和PAD4抗体,并进行线性回归、离群值计算和竞争实验。

主要发现

  • PAD2的33个精氨酸残基中自瓜氨酸化检出16个(48%),PAD4的27个精氨酸残基中检出7个(26%)。
  • 尽管存在显著自瓜氨酸化,自身抗体与天然和瓜氨酸化PAD2或PAD4的结合高度相关(ρ=0.927和ρ=0.903,均P<0.0001)。
  • 部分抗PAD阳性血清优先识别天然PAD2(40.5%)或瓜氨酸化PAD2(4.8%),或天然PAD4(11.7%)或瓜氨酸化PAD4(10.4%)。
  • 竞争实验证实大多数抗PAD反应性由不依赖瓜氨酸化状态的自身抗体池介导。

临床怎么用

  • 临床解读RA患者抗PAD抗体时应认识到其与ACPA不同,不依赖瓜氨酸化,检测时无需考虑瓜氨酸化状态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Citrullinated proteins are hallmark targets of autoantibodies in rheumatoid arthritis (RA). Our study was undertaken to determine the effect of autocitrullination on the recognition of peptidylarginine deiminases (PADs) 2 and 4 by autoantibodies in RA. METHODS: Autocitrullination sites in PAD2 and PAD4 were determined by mass spectrometry and literature review. Antibodies against native and autocitrullinated PADs in 184 patients with RA were detected by enzyme-linked immunosorbent assay. Linear regression analysis, outlier calculations, and competition assays were performed to evaluate antibody reactivity to native and citrullinated PADs. RESULTS: Autocitrullination of PAD2 and PAD4 was detected in 16 (48%) of 33 arginine residues and 7 (26%) of 27 arginine residues, respectively. Despite robust autocitrullination, autoantibodies bound similarly to native and citrullinated PAD2 or PAD4 (ρ = 0.927 and ρ = 0.903, respectively; each P < 0.0001). Although subsets of anti-PAD-positive sera were identified as exhibiting preferential recognition of native or citrullinated PAD2 (40.5% or 4.8%, respectively) or PAD4 (11.7% or 10.4%, respectively), competition assays confirmed that the majority of anti-PAD reactivity was attributed to a pool of autoantibodies that bound irrespective of citrullination status. CONCLUSION: Autocitrullination does not affect autoantibody reactivity to PADs in the majority of patients with RA, demonstrating that anti-PAD antibodies are distinct from anti-citrullinated protein antibodies in their dependence on citrullination for binding.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Darrah E, Davis RL, Curran AM, et al. Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis. Arthritis Rheumatol. 2020. PMID: 32255561. doi:10.1002/art.41276

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。